Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 29;63(2):e01907-18.
doi: 10.1128/AAC.01907-18. Print 2019 Feb.

In Vitro Activity of Omadacycline against Chlamydia pneumoniae

Stephan A Kohlhoff  1 , Natalia Huerta  2 , Margaret R Hammerschlag  2
Affiliations

In Vitro Activity of Omadacycline against Chlamydia pneumoniae

Stephan A Kohlhoff et al. Antimicrob Agents Chemother. .

Abstract

The in vitro activities of omadacycline, azithromycin, doxycycline, moxifloxacin, and levofloxacin were tested against 15 isolates of Chlamydia pneumoniae The minimum inhibitory concentration at which 90% of the isolates of C. pneumoniae were inhibited by omadacycline was 0.25 μg/ml (range, 0.03 to 0.5 μg/ml).

Keywords: Chlamydia pneumoniae; omadacycline; tetracyclines.

PubMed Disclaimer

References

    1. Hammerschlag MR, Kohlhoff SA, Gaydos CA. 2014. Chlamydia pneumoniae, p 2174–2182. In Mandell GL, Bennett JE, Dolin R (ed), Principles and Practice of Infectious Diseases, 8th ed Elsevier, Inc., Philadelphia, PA.
    1. Kohlhoff SA, Hammerschlag MR. 2015. Treatment of chlamydial infections: 2014 update. Expert Opin Pharmacother 16:205–212. doi:10.1517/14656566.2015.999041. - DOI - PubMed
    1. Pfaller MA, Rhomberg PR, Huband MD, Flamm RK. 2018. Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program. Diagn Microbiol Infect Dis 90:143–147. doi:10.1016/j.diagmicrobio.2017.10.010. - DOI - PubMed
    1. Waites KB, Crabb DM, Lui Y, Duffy LB. 2016. In vitro activities of omadacycline (PTK 0796) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother 60:7502–7504. doi:10.1128/AAC.01734-16. - DOI - PMC - PubMed
    1. Kohlhoff SA, Huband MD, Hammerschlag MR. 2014. In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother 58:7595–7596. doi:10.1128/AAC.03920-14. - DOI - PMC - PubMed

Publication types

MeSH terms